Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Trevi Therapeutics, Inc. (TRVI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/07/2022 |
SC 13G
| VIKING GLOBAL INVESTORS LP reports a 10% stake in Trevi Therapeutics, Inc. |
| 04/21/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Trevi Therapeutics, Inc. |
| 04/21/2022 |
SC 13G
| Fairmount Funds Management LLC reports a 9.9% stake in TREVI THERAPEUTICS, INC. |
| 04/18/2022 |
SC 13G
| Frazier Life Sciences Public Fund, L.P. reports a 10% stake in Trevi Therapeutics, Inc. |
| 04/08/2022 |
SC 13G
| MAI Capital Management reports a 5% stake in Trevi Therapeutics |
| 03/09/2022 |
SC 13G
| Rosalind Advisors, Inc. reports a 8.5% stake in Trevi Therapeutics, Inc. |
| 03/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2022 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 10% stake in Trevi Therapeutics, Inc. |
| 02/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/31/2020 |
SC 13G
| Lundbeckfond Invest A/S reports a 6.5% stake in Trevi Therapeutics, Inc. |
|
|